Table 1.
N = 202,995 | |
---|---|
n (%) | |
Year | |
2003 | 62,783 (30.9%) |
2006 | 66,397 (32.7%) |
2009 | 73,815 (36.4%) |
Age at admission | |
<1 y | 6,722 (3.3%) |
1 to 4 y | 48,461 (23.9%) |
5 to 9 y | 43,523 (21.4%) |
10 to 14 y | 42,801 (21.1%) |
> 15 y | 60,982 (30.0%) |
Gender | |
Male | 112,323 (55.3%) |
Female | 90,672 (44.67%) |
Payer^ | |
Public& | 73,973 (36.4%) |
Private | 113,027 (55.7%) |
Other | 15,678 (7.7%) |
Race ^ | |
White | 93,681 (46.2%) |
Black | 17,571 (8.7%) |
Hispanic | 37,877 (18.8%) |
Other (Asian, Native American, “other”) | 14,782 (7.3%) |
CCS category of primary diagnosis | |
Malignancy | 47,853 (23.6%) |
Chemotherapy | 74,955 (36.9%) |
Infection | 30,169 (14.9%) |
Non-Infectious toxicity | 40,725 (20.1%) |
Other | 9,293 (4.6%) |
&Represents both Medicaid and Medicare; ^Percentages do not sum to 100 owing to missing data. CCS indicates Clinical Classification Software.